OPC
Dược phẩm OPC ·HOSE ·2026Q1
● Maintaining
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, OPC posted slightly higher revenue but margins narrowed — the two forces offset each other, leaving the overall picture largely unchanged — the growth momentum has held across consecutive periods. What remains unclear is which side will dominate in coming periods.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.3 | 402.8 | 272.8 | 237.0 | 210.5 | 337.5 | 194.0 | 218.9 | 221.2 | 323.5 | 222.5 | 278.5 |
| Growth | -46% | +48% | +15% | +13% | -38% | +74% | -11% | -1% | -32% | +45% | -20% | — |
| Net Income | 19.8 | 37.7 | 32.6 | 21.9 | 24.1 | 31.1 | 22.6 | 28.1 | 33.4 | 24.2 | 31.6 | 37.9 |
| Net Margin | 9.15% | 9.37% | 11.97% | 9.26% | 11.46% | 9.21% | 11.65% | 12.82% | 15.09% | 7.49% | 14.22% | 13.60% |
Drivers of OPC's profit
Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE is broadly flat at 11.9% — the components are offsetting one another.
Is the profit sustainable?
Margins narrowed but earnings quality remains clean — pressure is mainly operational.
What is driving the margin?
Net margin narrowed to 9.93%, falling 1.1pp. The main pressure comes from SG&A / Revenue rose 1.3pp and Gross margin fell 0.1pp (with additional support from Net financial result / Revenue rose 0.3pp and Other profit / Revenue rose 0.1pp).
The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 0.44x equity, with a net cash position equivalent to 0.19x equity.
Inventory ended the period at 410.3bn, roughly 29.9% of total assets.
Over the last 12 months, working capital absorbed 112.0bn of cash, mainly because of higher receivables and higher inventories. Part of that drag was offset by higher payables.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 22.4 days versus the same period last year. The main moves came from DIO fell 24.8 days, DSO rose 3.5 days, and DPO rose 1.1 days.
Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.
Watchpoints
CCC stands at 292.5 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +3.5 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 59.9bn.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at -0.19x and interest coverage at 26.21x.
Debt maturity and the cash buffer remain the two key areas to monitor.
Some leverage signals are missing, so the current read should be treated as contextual.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 59.9bn in 2025, against investing cash flow of -13.1bn.
Post-investment cash flow was positive +46.8bn. Financing cash flow was negative +95.9bn.
CFO / net income was -0.11x.
After spending +28.2bn on fixed-asset investment, the business generated trailing free cash flow of −40.4bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is balanced but not yet fully stable — some components are moving the right way while others still need monitoring. This is a state to keep watching, with not enough signal to tilt the thesis either way. The brighter spot is earnings conversion is confirmed, with CFO/NI at -0.11x. The next item to monitor is capital efficiency. The main risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 292 days.
Improvement: earnings conversion looks more confirmed, with CFO / net income at -0.11x.
Watchpoint: Capital efficiency needs cycle context.
Key risk: working capital remains tied up for too long, with cash cycle at 292.5 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
1,123.0 | 968.6 | 1,004.9 | 1,171.6 | 1,123.8 |
|
Cost of Goods Sold
|
658.0 | 565.8 | 577.8 | 686.8 | 0.0 |
|
Gross Profit
|
464.9 | 402.8 | 427.1 | 484.9 | 441.0 |
|
Financial Expenses
|
6.3 | 6.9 | 7.5 | 8.1 | -11.6 |
|
Selling Expenses
|
222.1 | 187.8 | 180.9 | 208.7 | -190.3 |
|
General and Administrative Expenses
|
110.5 | 80.6 | 100.0 | 97.5 | -84.1 |
|
Operating Profit
|
148.2 | 138.1 | 156.1 | 179.6 | 159.3 |
|
Profit Before Tax
|
148.0 | 137.1 | 155.3 | 179.9 | 159.2 |
|
Net Income
|
116.4 | 109.5 | 122.3 | 142.4 | 123.4 |
|
Profit Attributable to Parent
|
115.9 | 107.1 | 122.2 | 142.1 | 126.4 |
|
Earnings per Share
|
1,538.00 | 1,421.00 | 1,634.00 | 2,000.00 | 4,755.07 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.